Medistim - Director's Dealing 2016

DISCLOSURE OF SHAREHOLDING IN MEDISTIM ASA

This joint disclosure is made by HealthInvest Partners

AB ("HealthInvest") for and on behalf of itself as

well as for and on behalf of HealthInvest Value Fund

and HealthInvest MicroCap Fund, in accordance with

Section 4-3 of the Norwegian Securities Trading Act.

HealthInvest is an independent Swedish fund management

company under the supervision of the Swedish Financial

Supervisory Authority (Finansinspektionen) since 2006.

HealthInvest offers actively managed healthcare funds

aimed at institutional and private clients.

HealthInvest´s investment approach includes a strong

emphasis on low valuations and in depth due diligence

to find potential catalysts to boost shareholder

value.

On January 11, 2016 (with settle date January 13,

2016), HealthInvest sold 700,000 shares in MEDISTIM

ASA ("MEDISTIM") for and on behalf of the HealthInvest

Value Fund. As a result of the transaction,

HealthInvest MicroCap Fund and HealthInvest Value Fund

crossed below the 5% threshold of Section 4-3 of the

Norwegian Securities Trading Act calculated on an

aggregate basis.

After the transaction mentioned above, HealthInvest

MicroCap Fund and HealthInvest Value Funds

shareholding in MEDISTIM amounts to 284,049 shares and

3,156 shares respectively. This equals 1.55% and 0.02%

of the issued shares and votes in MEDISTIM.

After the transaction, the aggregate shareholding in

MEDISTIM over which HealthInvest is authorized to

exercise voting rights on a discretionary basis

amounts to 287,205 shares, equaling 1.57% of the

issued shares and votes in MEDISTIM.

The above calculations are based on a total number of

outstanding shares in MEDISTIM of 18,337,336 shares.

No rights to shares in MEDISTIM are held by

HealthInvest MicroCap Fund, HealthInvest Value Fund or

any other fund managed by HealthInvest.

AI assistant